UY38144A - Inhibidores de la señalización mediada por tirosina cinasa - Google Patents

Inhibidores de la señalización mediada por tirosina cinasa

Info

Publication number
UY38144A
UY38144A UY38144A UY38144A UY38144A UY 38144 A UY38144 A UY 38144A UY 38144 A UY38144 A UY 38144A UY 38144 A UY38144 A UY 38144A UY 38144 A UY38144 A UY 38144A
Authority
UY
Uruguay
Prior art keywords
inhibitors
tyrosine kinase
signaling mediated
mediated
signaling
Prior art date
Application number
UY38144A
Other languages
English (en)
Inventor
M Friedman Michael
Martin Herold J
A Van Epps Stacy
C Breinlinger Eric
D Cowart Marlon
J Scanio Marc
Yulin Tsai Chien Ellen
J Hardee David
Huaqing Liu
Wei Qiu
R Vargo Thomas
P Webster Matthew
J Little Andrew
A Dunstan Theresa
A Katcher Matthew
A Schiedler David
A Argiriadi Maria
E Frank Kristine
R Schrimpf Michael
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of UY38144A publication Critical patent/UY38144A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se divulgan en el presente documento compuestos de Fórmula (I), y sales farmacéuticamente aceptables de los mismos, donde R1, R2, R3, R4a, R4b, X1, X2, X3, X4, X5, y n son como se definen en el presente documento, composiciones farmacéuticas que los comprenden, y métodos de preparación y uso.
UY38144A 2018-03-12 2019-03-12 Inhibidores de la señalización mediada por tirosina cinasa UY38144A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862641728P 2018-03-12 2018-03-12

Publications (1)

Publication Number Publication Date
UY38144A true UY38144A (es) 2019-10-31

Family

ID=65801866

Family Applications (1)

Application Number Title Priority Date Filing Date
UY38144A UY38144A (es) 2018-03-12 2019-03-12 Inhibidores de la señalización mediada por tirosina cinasa

Country Status (9)

Country Link
US (2) US10508113B2 (es)
EP (1) EP3539966A1 (es)
JP (2) JP6557436B1 (es)
AR (1) AR117398A1 (es)
AU (1) AU2019234574A1 (es)
CA (1) CA3090842A1 (es)
TW (1) TW201940483A (es)
UY (1) UY38144A (es)
WO (1) WO2019178079A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7212781B2 (ja) 2018-12-19 2023-01-25 ディスアーム セラピューティクス， インコーポレイテッド 神経保護剤と組み合わせたｓａｒｍ１の阻害剤
CN114075194B (zh) * 2020-08-13 2024-08-23 广东东阳光药业股份有限公司 取代的杂芳基化合物及其组合物和用途
CN114075221B (zh) * 2020-08-13 2024-08-23 广东东阳光药业股份有限公司 取代的杂芳基化合物及其组合物和用途
WO2022109580A1 (en) * 2020-11-20 2022-05-27 Janssen Pharmaceutica Nv Inhibition of tyk2 dependent signaling pathways
CN117043162A (zh) * 2021-05-19 2023-11-10 迈巴制药(南京)有限公司 Tyk2选择性抑制剂及其用途
IL312330A (en) 2021-10-25 2024-06-01 Kymera Therapeutics Inc TYK2 joints and their uses
CN118201922A (zh) * 2021-11-12 2024-06-14 百极优棠(广东)医药科技有限公司 Drak2抑制剂及其制备方法和应用
WO2023116748A1 (zh) * 2021-12-23 2023-06-29 广东东阳光药业有限公司 取代的杂芳基化合物及其组合物和用途
WO2024148247A2 (en) * 2023-01-06 2024-07-11 Ajax Therapeutics, Inc. Azaindazoles as jak2 inhibitors
WO2024193689A1 (zh) * 2023-03-23 2024-09-26 广东东阳光药业股份有限公司 吡啶并吡咯衍生物及其在药物中的用途
WO2024217523A1 (en) * 2023-04-20 2024-10-24 Myrobalan Therapeutics Nanjing Co. Ltd Selective tky2 inhibitors and uses thereof

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258476T3 (es) 1999-09-30 2006-09-01 Neurogen Corporation Ciertos heterociclos sustituidos con alquilendiaminas.
US7166293B2 (en) 2002-03-29 2007-01-23 Carlsbad Technology, Inc. Angiogenesis inhibitors
US7396940B2 (en) 2003-10-23 2008-07-08 Hoffmann-La Roche Inc. Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
US20050089936A1 (en) 2003-10-23 2005-04-28 Jianping Cai Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid amides
US7378532B2 (en) 2004-03-26 2008-05-27 Yung Shin Pharmaceutical Ind. Co., Ltd. Fused pyrazolyl compound
PT1730146E (pt) * 2004-03-30 2011-07-11 Vertex Pharma Azaindoles úteis como inibidores de jak e outras proteínas quinases
EP1773807A2 (en) 2004-06-14 2007-04-18 Takeda San Diego, Inc. Kinase inhibitors
JP2008520745A (ja) 2004-11-22 2008-06-19 バーテックス ファーマシューティカルズ インコーポレイテッド Ｒｈｏキナーゼの二環式阻害剤
US7598380B2 (en) 2005-08-03 2009-10-06 Bristol-Myers Squibb Company Method of preparation of azaindole derivatives
NZ569087A (en) 2005-12-13 2011-09-30 Schering Corp Polycyclic indazole derivatives that are ERK inhibitors
KR20130041313A (ko) 2006-01-17 2013-04-24 버텍스 파마슈티칼스 인코포레이티드 야누스 키나제의 억제제로서 유용한 아자인돌
CA2645137A1 (en) 2006-03-07 2007-09-13 James F. Blake Heterobicyclic pyrazole compounds and methods of use
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP2137158A4 (en) 2007-02-28 2012-04-18 Methylgene Inc LOW-MOLECULAR INHIBITORS OF PROTEINARGININE METHYLTRANSFERASES (PRMTS)
CL2008001633A1 (es) 2007-06-05 2008-12-12 Schering Corp Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer.
WO2009000832A2 (en) 2007-06-25 2008-12-31 Boehringer Ingelheim International Gmbh Chemical compounds
WO2009011912A1 (en) 2007-07-18 2009-01-22 Bristol-Myers Squibb Company A composition for treating hiv comprising virus-like particles
CA2703125C (en) 2007-10-25 2012-08-28 David J. Guerin Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
JP5489235B2 (ja) 2007-11-15 2014-05-14 ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド Ｎ含有複素環式化合物
EP2231143B1 (en) 2007-12-13 2013-07-03 Merck Sharp & Dohme Corp. 5H-pyrido[4,3-b]indoles as INHIBITORS OF JANUS KINASES
KR20100115789A (ko) 2008-02-04 2010-10-28 머큐리 테라퓨틱스, 인코포레이티드 Ａｍｐｋ 조절자
EP3031324A3 (en) 2008-06-10 2016-09-07 AbbVie Inc. Tricyclic kinase inhibitors
JP2011525892A (ja) 2008-06-18 2011-09-29 メルク・シャープ・エンド・ドーム・コーポレイション Ｊａｎｕｓキナーゼの阻害剤
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
DE102008063992A1 (de) 2008-12-19 2010-09-02 Lerner, Zinoviy, Dipl.-Ing. Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
CA2748943A1 (en) * 2009-02-09 2010-08-12 Supergen, Inc. Pyrrolopyrimidinyl axl kinase inhibitors
WO2010100144A1 (en) 2009-03-04 2010-09-10 Merck Serono S.A. Fused bicyclic compounds as inhibitors for pi3 kinase
TW201040191A (en) 2009-03-27 2010-11-16 Abbott Gmbh & Co Kg Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
DK2506716T3 (en) 2009-12-01 2017-09-04 Abbvie Inc HIS UNKNOWN TRICYCLIC RELATIONS
CN102711470A (zh) 2009-12-01 2012-10-03 雅培制药有限公司 新的三环化合物
WO2011079231A1 (en) 2009-12-23 2011-06-30 Gatekeeper Pharmaceutical, Inc. Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
RU2012141536A (ru) 2010-03-17 2014-04-27 Ф. Хоффманн-Ля Рош Аг Имидазопиридины, композиции и способы применения
EP2588105A1 (en) 2010-07-01 2013-05-08 Cellzome Limited Triazolopyridines as tyk2 inhibitors
WO2012022045A1 (en) 2010-08-20 2012-02-23 Hutchison Medipharma Limited Pyrrolopyrimidine compounds and uses thereof
WO2012022265A1 (en) 2010-08-20 2012-02-23 Hutchison Medipharma Limited Pyrrolopyrimidine compounds and uses thereof
EP2611812A1 (en) 2010-09-01 2013-07-10 Ambit Biosciences Corporation Thienopyridine and thienopyrimidine compounds and methods of use thereof
WO2012030924A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Azolopyridine and azolopyrimidine compounds and methods of use thereof
RU2013126041A (ru) 2010-11-19 2014-12-27 Ф.Хоффманн-Ля Рош Аг Пиразолопиридины и пиразолопиридины и их применение в качестве ингибиторов tyk2
CA2819373A1 (en) 2010-12-09 2012-06-14 Amgen Inc. Bicyclic compounds as pim inhibitors
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
US20140303163A1 (en) 2011-03-24 2014-10-09 Ying Luo Use of kinase inhibitors in preventing and treating inflammatory disorder
EP2742046A1 (en) 2011-08-12 2014-06-18 F.Hoffmann-La Roche Ag PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
CN103827115A (zh) 2011-09-20 2014-05-28 弗·哈夫曼-拉罗切有限公司 咪唑并吡啶化合物、组合物和使用方法
WO2013078254A1 (en) 2011-11-22 2013-05-30 Array Biopharma Inc. Bicyclic heteroaryl derivatives as kinase inhibitors
WO2013125543A1 (ja) 2012-02-20 2013-08-29 武田薬品工業株式会社 複素環化合物
GB201204125D0 (en) 2012-03-08 2012-04-25 Karus Therapeutics Ltd Compounds
JP5925723B2 (ja) 2012-04-13 2016-05-25 田辺三菱製薬株式会社 アミド誘導体の医薬用途
JP2014024838A (ja) 2012-06-21 2014-02-06 Taisho Pharmaceutical Co Ltd 縮合複素環化合物を有効成分として含有する血糖低下作用薬
WO2014026327A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2014047662A2 (en) 2012-09-24 2014-03-27 Whitehead Institute For Biomedical Research Indazole derivatives and uses thereof
WO2014074670A1 (en) 2012-11-08 2014-05-15 Bristol-Myers Squibb Company ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα
ES2914793T3 (es) 2012-11-08 2022-06-16 Bristol Myers Squibb Co Compuestos heterocíclicos sustituidos con amida, útiles como moduladores de la respuesta de IL-12, IL-23 y/o IFN-alfa
SG11201503396UA (en) 2012-11-08 2015-05-28 Bristol Myers Squibb Co ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFNα RESPONSES
WO2014130693A1 (en) 2013-02-25 2014-08-28 Pharmacyclics, Inc. Inhibitors of bruton's tyrosine kinase
EP2970276A1 (en) 2013-03-12 2016-01-20 AbbVie Inc. Dihydro-pyrrolopyridinone bromodomain inhibitors
EP3003302A4 (en) 2013-05-24 2016-12-14 Scripps Research Inst BIDENTATE-BINDING MODULATORS OF LRRK2 AND JNK KINASES
EA029499B9 (ru) * 2013-08-02 2018-07-31 Пфайзер Инк Ингибиторы rorc2 и способы их применения
US9718818B2 (en) 2013-08-22 2017-08-01 Merck Sharp & Dohme Corp. Compounds inhibiting leucine-rich repeat kinase enzyme activity
TWI582077B (zh) 2013-11-07 2017-05-11 必治妥美雅史谷比公司 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物
WO2015089143A1 (en) 2013-12-10 2015-06-18 Bristol-Myers Squibb Company Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
WO2015091584A1 (en) 2013-12-18 2015-06-25 F. Hoffmann-La Roche Ag Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors
AU2015222865B2 (en) 2014-02-28 2019-06-20 Takeda Pharmaceutical Company Limited TYK2 inhibitors and uses thereof
CN105712998B (zh) 2014-12-05 2019-12-13 上海润诺生物科技有限公司 氮杂吲哚类衍生物、其制备方法及其在医药上的应用
KR101987994B1 (ko) * 2015-01-28 2019-06-11 제이엔 테라퓨틱스 치환된 이미다조[1,2-a]피리딘-2-일아민 화합물, 및 약학 조성물 및 이의 사용 방법
ES2930585T3 (es) 2015-02-27 2022-12-19 Nimbus Lakshmi Inc Inhibidores de TYK2 y usos de los mismos
CN111440189B (zh) 2015-04-24 2022-08-09 广州再极医药科技有限公司 稠环嘧啶氨基衍生物、其制备方法、中间体、药物组合物及应用
CN106188060A (zh) 2015-04-29 2016-12-07 厦门大学 嘧啶并吡咯类化合物、其制备方法、药用组合物及其应用
JP6802263B2 (ja) * 2015-09-02 2020-12-16 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
WO2017087590A1 (en) 2015-11-18 2017-05-26 Bristol-Myers Squibb Company Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
GB201521059D0 (en) 2015-11-30 2016-01-13 Isis Innovation Inhibitors of metallo-beta-lactamases
JP6860267B2 (ja) * 2015-12-11 2021-04-14 シチュアン ケルン−バイオテック バイオファーマシューティカル カンパニー リミテッド アゼチジン誘導体、その調製方法、及びその使用
WO2017133667A1 (en) 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyrimidine and pyridine derivatives and use in treatment, amelioration or prevention of influenza thereof
WO2017133670A1 (en) 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2017133665A1 (en) 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 6,7-diazaindazole and 6,7-diazaindole derivatives and use in treatment, amelioration or prevention of influenza thereof
KR20180134849A (ko) 2016-02-12 2018-12-19 파맥시스 엘티디 라이실 옥시다제의 할로알릴아민 인돌 및 아자인돌 유도체 억제제 및 이의 용도
JP6505956B2 (ja) * 2016-02-24 2019-04-24 ファイザー・インク ＪＡＫ阻害剤としてのピラゾロ［１，５−ａ］ピラジン−４−イル誘導体
US10836770B2 (en) 2016-10-07 2020-11-17 Bristol-Myers Squibb Company Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses
TWI763722B (zh) 2016-10-14 2022-05-11 美商林伯士拉克許米公司 Tyk2抑制劑及其用途
JP7082120B2 (ja) 2016-10-21 2022-06-07 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤およびその使用
KR102477063B1 (ko) 2016-10-28 2022-12-12 브리스톨-마이어스 스큅 컴퍼니 Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 헤테로비시클릭 화합물
EP3541817B1 (en) 2016-11-17 2020-12-23 Bristol-Myers Squibb Company Imidazopyridazine modulators of il-12, il-23 and/or ifn-alpha
JP7046092B2 (ja) 2016-12-13 2022-04-01 ブリストル－マイヤーズ スクイブ カンパニー Ｉｌ－１２、ｉｌ－２３および／またはｉｆｎアルファ応答の調節剤としてのホスフィンオキシドアルキルアミド置換ヘテロアリール化合物
CN108341814B (zh) * 2017-01-23 2021-09-03 上海翔锦生物科技有限公司 Jak激酶抑制剂及其应用
JP7160824B2 (ja) 2017-03-08 2022-10-25 ニンバス ラクシュミ， インコーポレイテッド Ｔｙｋ２阻害剤、使用およびその製造のための方法
WO2018234354A1 (en) 2017-06-20 2018-12-27 Grünenthal GmbH NOVEL SUBSTITUTED 3-INDOLE AND 3-INDAZOLE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS
CN111194317A (zh) 2017-07-28 2020-05-22 林伯士拉克许米公司 Tyk2抑制剂与其用途

Also Published As

Publication number Publication date
JP2019156839A (ja) 2019-09-19
JP2019194243A (ja) 2019-11-07
US20200255423A1 (en) 2020-08-13
JP6557436B1 (ja) 2019-08-07
AU2019234574A1 (en) 2020-09-03
WO2019178079A9 (en) 2019-12-12
US20190276450A1 (en) 2019-09-12
EP3539966A1 (en) 2019-09-18
CA3090842A1 (en) 2019-09-19
US10508113B2 (en) 2019-12-17
WO2019178079A1 (en) 2019-09-19
AR117398A1 (es) 2021-08-04
TW201940483A (zh) 2019-10-16

Similar Documents

Publication Publication Date Title
UY38144A (es) Inhibidores de la señalización mediada por tirosina cinasa
NI202000078A (es) Compuestos heteroaril tetracíclicos
CL2017001675A1 (es) Derivados de quinazolina utilizados para tratar el vih
ECSP22046699A (es) Inhibidores de kras g12c
UY37710A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
BR112021024108A2 (pt) Inibidores de tead e usos dos mesmos
BR112021024224A2 (pt) Inibidores de tead e usos dos mesmos
UY38076A (es) Derivados de tetrahidroquinazolina útiles como agentes anticáncer
CO2017009891A2 (es) Inhibidores de inhibidores del factor beta de crecimiento de transformación (tgf-beta)
CL2016002148A1 (es) Derivados de fenilen-1,5-diamina 2,4-disustituidos y aplicaciones de los mismos, y composiciones farmacéuticas y composiciones farmacéuticamente aceptables preparadas a partir de los mismos.
CL2016001973A1 (es) Derivados de nucleosido sustituidos con 4' -difluorometilo como inhibidores de la replicación de arn de la influenza.
CL2016002179A1 (es) Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b.
UY37645A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
UY36649A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
UY37564A (es) Aislados de lysinibacillus y usos de los mismos
UY37646A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
CL2019001993A1 (es) Inhibidores selectivos de jak1.
ECSP17069696A (es) Compuestos novedosos
DOP2021000062A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
CR20170484A (es) Azabenzimidazoles y su uso como moduladores del receptor ampa
CL2019002900A1 (es) Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton.
UY36003A (es) Derivados de amida, procesos de preparación y composiciones, útiles en afecciones asociadas con el receptor sub-tipo 1 de orexina.
CO2019011546A2 (es) Compuestos y métodos para el tratamiento de enfermedades parasitarias
CO2020007044A2 (es) Derivados de pirrol como inhibidores de acc
CL2019001991A1 (es) Moduladores del receptor de estrógeno.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20240513